Senior Director, Head of New Product Strategy and Commercialization at Sarepta Therapeutics

Cambridge, Massachusetts, United States -

Full Time

Start Date

Immediate

Expiry Date

18 Sep, 26

Salary

278000.0

Posted On

20 Jun, 26

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Commercial Strategy, Brand Marketing, Product Management, Rare Disease Launch, Cross-functional Leadership, Market Dynamics Analysis, Target Product Profile Development, Payer Engagement, Market Potential Assessment, Business Development, Due Diligence, Strategic Roadmap Planning, Risk Mitigation, Stakeholder Management, Commercial Acumen, Drug Development

Industry

Biotechnology Research

Description

Why Sarepta? Why Now? The promise of genetic medicine has arrived, and Sarepta is at the forefront. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. In 2023, we launched our fourth therapy and the first ever gene therapy to treat Duchenne. We’re looking for people who see unlimited potential in themselves and who are motivated by an unwavering commitment to patients. What Sarepta Offers At Sarepta, we care deeply about all the people in our community and believe in the importance of supporting them in all aspects of their lives. We aspire to maintain a culture that acknowledges people bring their whole selves to work, and we will strive to help everyone in our community integrate their work and personal lives while maintaining productivity. We are committed to offering a range of benefits and work-life resources designed to support people in the following areas: Physical and Emotional Wellness Financial Wellness Support for Caregivers For a full list of our comprehensive benefits, see our website: https://www.sarepta.com/join-us The Importance of the Role Job Title: Head of New Product Strategy and Commercialization Department: Commercial Operations Reports to: VP, Commercial Operations Location: Cambridge, MA The Opportunity to Make a Difference The Position: The Head of New Product Strategy and Commercialization is responsible for the global commercial strategy of our pipeline of best-in-class siRNA assets. As the Head of New Product Strategy and Commercialization, you will co-lead the program Asset Team with an R&D co-lead accountable for shaping and advancing asset strategy in partnership with cross-functional peers. The individual must be able to drive timely, high-quality decisions, align diverse stakeholders across a complex matrix organization, and be accountable for recommendations and outcomes to executive management that impact the asset. In your capacity as program Asset Co-Lead you will work across the portfolio and in partnership with the Global Brand Team, Global Development Team, Medical Affairs, Market Access, Commercial Operations, Clinical Development, and Patient Advocacy. For our later-stage assets, you will be accountable for actionable brand strategic and tactical plans to optimize launch readiness and commercial success, including disease awareness communications for multiple stakeholders, such as HCPs and patients/caregivers, to ensure market preparation. This role also partners closely with Business Development to provide commercial assessments of external opportunities and support discussions on potential external partnerships. More about You Primary Responsibilities Include: Head of New Product Strategy and Commercialization Own the asset strategic roadmap and long-term vision, ensuring commercial perspective is embedded in enterprise decision-making Be accountable for delivery of the asset objectives against corporate goals, including key strategic recommendations, trade-off decisions, and execution milestones Drive asset-level cross-functional decision-making by integrating functional input, resolving ambiguity, and escalating critical issues when needed Identify, assess, and elevate asset-level risks and opportunities, with clear ownership of mitigation strategies and decision follow-through Lead the development of target product profiles for pipeline assets, based on thorough understanding of market dynamics and potential future trends Partner with Market Access, Medical, and HEOR to build evidence and value strategies that support payer engagement and access for commercialization Partner with Commercial Operations and Manufacturing to develop integrated forecasts and market potential assessments Lead commercial assessments of potential therapeutic targets and programs Desired Education and Skills: Bachelor’s degree with 15+ years or (MBA preferred with 13+ years) of experience in biotech/pharma strategic roles with a track record demonstrating accountability, sense of urgency and cross functional leadership Strong commercial acumen with significant experience in commercial strategy, brand marketing, brand strategy, and product management is required; global product launch experience in rare disease is preferred Extensive understanding of drug development and proven track record of using deep customer and market insight to deliver informed recommendations to R&D decisions that ensure attainment of commercial objectives Excellent organizational skills, sufficient to multi-task in an extremely fast-paced environment with changing priorities Strong leadership abilities to influence and lead across a matrix environment, drive timely cross-functional decisions, and be accountable for asset-level recommendations and outcomes Experience in high science, competitive markets required Experience supporting business development through commercial opportunity assessment and due diligence, including evaluation of external assets, markets, and strategic fit Candidates must be authorized to work in the U.S. Sarepta Therapeutics offers a competitive compensation and benefit package. Sarepta Therapeutics is an Equal Opportunity/Affirmative Action employer and participates in e-Verify. What Now? We’re always looking for solution-oriented, critical thinkers. So, if you’re comfortable with ambiguity and candor, relish challenging yourself, and place kindness and integrity at the forefront of how you approach your peers and work, then we encourage you to apply. #LI-Hybrid Blank This position is hybrid, you will be expected to work on site at one of Sarepta’s facilities in the United States and/or attend Company-sponsored in-person events from time to time. The targeted salary range for this position is $222,400 - $278,000 per year. Sarepta is making a good faith effort to be transparent and accurate around our hiring ranges. The salary offer is commensurate with Sarepta’s compensation philosophy and considers factors including, but not limited to, education, training, experience, external market conditions, criticality of role, and internal equity. Candidates must be authorized to work in the U.S. Sarepta Therapeutics offers a competitive compensation and benefit package. Sarepta Therapeutics is an Equal Opportunity/Affirmative Action employer and participates in e-Verify. Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold a leadership position in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases. Our deep pipeline is driven by our multi-platform technologies in siRNA, RNA and gene therapy. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Responsibilities

Lead the global commercial strategy and strategic roadmap for siRNA assets, co-leading the program Asset Team to drive high-quality decisions. Accountable for brand strategic plans, launch readiness, and commercial assessments of external opportunities in partnership with cross-functional teams.